On Air Now

Current Show

Sean Hannity   2:00 PM - 5:00 PM

Call Sean at 800-941-7326

Show Info »

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 1320 AM Sioux Falls, SD 107.9 FM Sioux Falls, SD

Weather

Current Conditions(Sioux Falls,SD 57104)

More Weather »
75° Feels Like: 75°
Wind: SSE 21 mph Past 24 hrs - Precip: 0.19”
Current Radar for Zip

Today

Thunderstorms/Wind 80°

Tonight

Isolated Thunderstorms 68°

Tomorrow

Sunny 90°

Alerts

Incorrect biopsy results cloud Nymox Pharma prostate cancer study

(Reuters) - Nymox Pharmaceutical Corp said its experimental prostate cancer drug reduced the progression of cancer in patients, but it could not determine if the study succeeded in meeting pre-determined goals due to a high rate of incorrect biopsies.

In the mid-stage study, patients receiving a single injection of the drug, NX-1207, had less cancer progression in the treated area than in untreated patients.

The main goal of the trial was to show a significantly higher number of patients with undetectable prostate cancer after 45 days of treatment, compared to untreated patients.

However, the company was unable to assess the drug's benefit because of a high percentage of false negative biopsies - a result suggesting there is no cancer present when it actually is - in the untreated patients' group.

Nymox's shares were down 3 percent at $4.98 in morning trading on the Nasdaq.

(Reporting by Esha Dey in Bangalore; Editing by Maju Samuel)

Comments